StonvexLoading…
StonvexStonvexStonvexCore line items from VNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-03 | Annual 2025 2025-12-31 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $750.60M | $3.08B | $2.27B | $1.51B |
Operating Income | $134.80M | $561.60M | $408.90M | $266.50M |
Net Income | $94.30M | $406.10M | $282.60M | $91.90M |
EPS (Diluted) | $0.66 | $2.76 | $1.90 | $1.21 |
Total Assets | $4.13B | $4.37B | $4.38B | $4.38B |
Total Liabilities | $2.87B | $3.12B | $3.14B | $3.17B |
Cash & Equivalents | $233.80M | $492.20M | $433.80M | $364.20M |
Free Cash Flow OCF − CapEx | $24.80M | $441.10M | $266.30M | $176.00M |
Shares Outstanding | 140.90M | 142.20M | 145.50M | 147.00M |